Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by 김은석, Chief Executive Officer. Director active across 1 company, notably 대화제약. Cumulatively, 28 disclosures have been recorded. History available since 5 March 2026. The latest transaction was disclosed on 27 April 2026 (Purchase). Regulator: DART (FSS). All data is free.
Kim Eun-seok is the CEO of 대화제약. He leads the company and is responsible for overall strategy and operations management. His leadership is essential for the development and growth of 대화제약 in the market.